July 8, 2025 – The FDA has approved the first-ever pill to stop attacks of a rare genetic swelling disorder while they’re happening. The drug, known as sebetralstat but sold as Ekterly, is for adults… Read more
Epkinly (epcoritamab-bysp) is a type of cancer treatment called a bispecific antibody that helps your immune system find and destroy certain cancer cells by connecting immune cells (T cells) to cancer cells (B cells). Epkinly… Read more
The FDA has approved Rasonque (daraxonrasib) to treat adults with advanced pancreatic cancer. The drug is for people with pancreatic adenocarcinoma that has spread to other parts of the body. It is used when patients… Read more
Nereus (tradipitant) is a new prescription medicine approved by the FDA to help prevent nausea and vomiting caused by motion (motion sickness) in adults, such as during car rides, boat trips, or flights. Motion sickness… Read more
Aqvesme (mitapivat) is a new oral medicine approved by the FDA for treating anemia in adults with alpha- or beta-thalassemia, including those who need and those who don’t require regular blood transfusions. Thalassemia is a… Read more
Yartemlea (narsoplimab-wuug) is a new medicine approved by the FDA for treating a rare and serious condition called transplant-associated thrombotic microangiopathy (TA-TMA) in adults and children ages 2 years or older. TA-TMA is a serious… Read more
Vybrique (sildenafil) is a new form of treatment for erectile dysfunction (ED) in adult men. It’s the first version of sildenafil available in the U.S. as a single-dose oral film that dissolves on your tongue… Read more
Darzalex Faspro is an injectable medicine used to treat adults with multiple myeloma, a type of blood cancer, and light chain (AL) amyloidosis, a rare condition caused by the buildup of abnormal proteins in organs.… Read more
Wakix (pitolisant) is a prescription medication used to treat narcolepsy, a long-term neurological sleep disorder that causes excessive daytime sleepiness and, in many cases, cataplexy (sudden muscle weakness triggered by strong emotions). The FDA has… Read more
The FDA has approved a new combination treatment for adults with certain cancers of the blood and lymphatic system. The targeted regimen combines Calquence (acalabrutinib) tablets with Venclexta (venetoclax) for adults with previously untreated chronic lymphocytic… Read more